Immunovant, Inc. IMVT Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s net change in cash?
- Immunovant, Inc. (IMVT) reported net change in cash of $472.66M in Q4 2025.
- How has Immunovant, Inc.'s net change in cash changed year-over-year?
- Immunovant, Inc.'s net change in cash increased by 581.0% year-over-year, from -$98.26M to $472.66M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.